Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma

Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Journal der Deutschen Dermatologischen Gesellschaft Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 31-31

Conference Proceedings Title: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Authors with CRIS profile

Lucie Heinzerling Department of Dermatology

Involved external institutions

Universitätsklinikum Heidelberg DE Germany (DE) Johannes Gutenberg-Universität Mainz (JGU) DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE)

How to cite

APA:

Naoum, C., Majenka, P., Loquai, C., Kaehler, K., Heinzerling, L., Dudda, M., & Hassel, J. (2019). Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 31-31). HOBOKEN: WILEY.

MLA:

Naoum, C., et al. "Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma." Proceedings of the JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT HOBOKEN: WILEY, 2019. 31-31.

BibTeX: Download